Modelling study finds benefits to widening PEP access but it’s unclear how to implement it
RTI International/Ruth McDowallMaking the commonly prescribed antiretroviral regimen of tenofovir, lamivudine and dolutegravir available in the community as post-exposure prophylaxis after condomless sex, without a prescription, would reduce HIV acquisition by 31% over 20 years in African countries, according to a modelling study published in Lancet Global Health.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
-
[CROI 2026] HIV i-Base: Only three new HIV cases on lenacapavir PrEP: updates from PURPOSE-1 and -2
-
aidsmap: DoxyPEP halves overall syphilis cases, with possible indirect benefits for women
-
[Press release] US and Global Fund expand commitment to long-acting HIV prevention as country rollout of lenacapavir accelerates
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.